Biotech company designing next-generation gene-writing tools to cure genetic diseases

Biotechnology company that creates next-generation genetic writing tools to make advanced therapies safer, more effective and enable the integration of large amounts of information.

CEO: Avencia Sánchez-Mejías.

INVESTED COMPANY
2022